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Abstract
Background
Previously we reported that Kala-azar patients show progressive decrease in serum choles-
terol as a function of splenic parasite burden. Splenic macrophages (MΦ) of Leishmania
donovani (LD) infected mice show decrease in membrane cholesterol, while LD infected
macrophages (I-MΦ) show defective T cell stimulating ability that could be corrected by lipo-
somal delivery of cholesterol. T helper cells recognize peptide antigen in the context of
class II MHCmolecule. It is known that the conformation of a large number of membrane
proteins is dependent on membrane cholesterol. In this investigation we tried to understand
the influence of decreased membrane cholesterol in I-MΦ on the conformation of MHC-II
protein and peptide-MHC-II stability, and its bearing on the antigen specific T-cell activation.
Methodology/Principal Findings
MΦ of CBA/j mice were infected with Leishmania donovani (I-MΦ). Two different anti-Aκ
mAbs were used to monitor the status of MHC-II protein under parasitized condition. One of
them (11.5–2) was conformation specific, whereas the other one (10.2.16) was not. Under
parasitized condition, the binding of 11.5–2 decreased significantly with respect to the nor-
mal counterpart, whereas that of 10.2.16 remained unaltered. The binding of 11.5–2 was
restored to normal upon liposomal delivery of cholesterol in I-MΦ. By molecular dynamics
(MD) simulation studies we found that there was considerable conformational fluctuation in
the transmembrane domain of the MHC-II protein in the presence of membrane cholesterol
than in its absence, which possibly influenced the distal peptide binding groove. This was
evident from the faster dissociation of the cognate peptide from peptide-MHC complex
under parasitized condition, which could be corrected by liposomal delivery of cholesterol in
I-MΦ.
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0004710 May 23, 2016 1 / 23
a11111
OPEN ACCESS
Citation: Roy K, Mandloi S, Chakrabarti S, Roy S
(2016) Cholesterol Corrects Altered Conformation of
MHC-II Protein in Leishmania donovani Infected
Macrophages: Implication in Therapy. PLoS Negl
Trop Dis 10(5): e0004710. doi:10.1371/journal.
pntd.0004710
Editor: Hira L Nakhasi, U.S. Food and Drug
Administration and Center for Biologics Evaluation
and Research, UNITED STATES
Received: January 5, 2016
Accepted: April 23, 2016
Published: May 23, 2016
Copyright: © 2016 Roy et al. This is an open access
article distributed under the terms of the Creative
Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information files.
Funding: This work was supported by the Council of
Scientific and Industrial Research, New Delhi, India
and Network Project (code: NWP 0005) and J.C.
Bose Fellowship (SB/S2/JCB-65/2014) to SR. SC
acknowledges Council of Scientific and Industrial
Research-Indian Institute of Chemical Biology HOPE
network project (code: BSC0114) for funding. KR is
thankful to Council of Scientific and Industrial
Research for fellowship. SM is thankful for
Conclusion
The decrease in membrane cholesterol in I-MΦmay lead to altered conformation of MHC II,
and this may contribute to a faster dissociation of the peptide. Furthermore, liposomal deliv-
ery of cholesterol in I-MΦ restored its normal antigen presenting function. This observation
brings strength to our previous observation on host directed therapeutic application of lipo-
somal cholesterol in experimental visceral leishmaniasis.
Author Summary
The disease visceral leishmaniasis is caused by the protozoan parasite Leishmania dono-
vani (LD). One of the hallmarks of the disease is immune suppression. The parasites repli-
cate within the macrophages and dendritic cells, and such cells are known as antigen
presenting cells (APCs). APCs present peptide to T-helper cells in association with the
transplantation antigen-II (MHC-II). The infected macrophages show decrease in mem-
brane cholesterol leading to increase in membrane fluidity. The membrane cholesterol is
important for maintaining conformation of membrane proteins. Here we show that con-
formation of MHC-II protein is altered in parasitized macrophages, which results faster
dissociation of peptide from peptide-MHC-II complex as compared to normal counter-
part. The conformational change in MHC-II protein is also supported by molecular
dynamic simulation studies, as there is considerable structural fluctuation of MHC-II pep-
tide binding domain in presence and absence of cholesterol. This observation indicated
that cholesterol is important for maintaining conformation of MHC-II protein and stabil-
ity of the peptide-MHC complex. Thus, Leishmania parasites by modulating membrane
cholesterol influence above processes leading to defective T-cell stimulation in leishmania-
sis. The above defects displayed by infected macrophages could be corrected by liposomal
delivery of cholesterol indicating a possible therapeutic role of liposomal cholesterol in
infection.
Introduction
The disease visceral leishmaniasis or kala azar is characterized by the depression in the cellular
immune response and the cause of which is largely unknown [1, 2]. The protozoan parasite,
Leishmania donovani (LD), the causative agent of visceral leishmaniasis, replicates within the
macrophage or dendritic cells of the mammalian hosts [3]. The parasites during their intracel-
lular life cycle in the macrophages disrupt lipid rafts [4] and are unable to form synapse with
antigen specific T-cells [5]. Previously, we showed that the kinetic stability of the peptide-
MHC complex is compromised in LD infection [6]. The above-mentioned defects are perhaps
due to increase in membrane fluidity [4], which could arise due to decrease in membrane cho-
lesterol [5]. We also showed that splenic adherent cells of L. donovani infected hamsters show
40% decrease in membrane cholesterol and infected hamsters receiving liposomal cholesterol
but not analogue liposomal cholesterol showed normal membrane cholesterol [5]. This
infected hamsters receiving liposomal cholesterol but not liposomal cholesterol analogue show
significant decrease in the hepatic and splenic parasite burden indicating a therapeutic role of
liposomal cholesterol in experimental L. donovani infection. Similarly, ex-vivo infection of
macrophages with L. donovani shows 50% decrease in membrane cholesterol [7]. Thus,
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infection with L. donovani leads to generalized defects in cholesterol metabolism in the infected
hosts. As a part of the molecular mechanism to explain how parasite cause generalized defects,
we show that miR122 maturation is compromised in L. donovani infection. miR122 controls
cholesterol metabolism in liver and its maturation from pre-miR122 to mature miR122 is con-
trolled by the protein known as 'Dicer 1'. The parasites by using surface protease, gp63, target
pre-miRNA processor Dicer 1 and thus inhibit maturation of miR122. Restoration of miR122
or Dicer 1 level in experimental visceral leishmaniasis increased serum cholesterol and reduced
liver parasite burden [8]. Thus, due to absence of miR122 the overall cholesterol metabolism is
decreased leading to generalized defects in cholesterol biosynthesis in L. donovani infected
hosts. Furthermore, parasites may exploit membrane cholesterol for its own benefit during
entry into host cells although the cause of membrane cholesterol depletion by LD parasite is
not very clear yet. It is to be noted that there is an inverse correlation between membrane cho-
lesterol and membrane fluidity [9]. The membrane cholesterol is important for the lateral
mobility of the membrane proteins [9]. Previously, we also showed that INF-γ receptor sub-
units, R1 and R2, move beyond the Förster radii in LD infected macrophages and as a conse-
quence IFN-γ is unable to transduce the signals in the intracellular compartment despite
binding to one of its receptor subunits [7]. The above defective attributes in LD infected macro-
phages could be corrected by the liposomal delivery of cholesterol [7]. We have shown that
there is a significant increase in lateral mobility of membrane protein in LD infected cells,
which is corrected by liposomal cholesterol treatment [10].
Using conformation specific mAb directed against MHC-II protein, we could show that
binding of such antibody is significantly decreased in methyl β-cyclo dextrin treated macro-
phages whereas the binding of non-conformation specific antibody remains unaltered [11].
CRAC (cholesterol recognition amino acid consensus) region has first been identified as a
high-affinity cholesterol binding motif in the C-terminus of the peripheral benzodiazepine
receptor [12]. This motif is found in many cholesterol-dependent G protein coupled receptors
(GPCRs) such as receptors for oxytocin and 5HT1A, the sigma-1 receptors [13], etc. One of
the major proteins of peripheral myelin, the P0 protein undergoes a cholesterol-dependent
conformation change [14]. This protein has a single transmembrane domain and possesses
CRAC motifs on both sides of the transmembrane segment [14]. Presence of another type of
cholesterol binding motif ‘Cholesterol Consensus Motif’ (CCM) has been described in the
β2-adrenergic receptor [15].
Oxytocin, cholecystokinin, galanin and nicotinic acetylcholine receptors have been shown
to require membrane cholesterol for their function [16]. Many virus proteins have cholesterol
binding motif. HIV gp41, influenza A M2 and SFV E1 proteins are vastly different in structure
and function. However, they have one common flexible domain, which undergo conforma-
tional transition during the membrane restructuring processes and contain cholesterol binding
sites [17]. There are reports of pathological effects of reduced cholesterol level on the mito-
chondrial dysfunction for both complexes III and IV [18].
Our earlier study showed that cholesterol interacts with transmembrane (TM) domain of
MHC-II protein through CRAC motifs and alters its alpha-helical content [11]. Mutation of
critical amino acids of CRAC motif (F240, L243 and F246) in TM domain weakens interaction
with cholesterol. The Kd values observed upon interaction between cholesterol and wild type
TM-domain and its corresponding mutated TM-domain were 47 nM and 2770 nM, respec-
tively [11]. Furthermore, transfection of CHO-cells with a mutated form of Akβ at the CRAC
motif and wild type Akα showed normal assembly of Akα and Akβ chains but such APCs were
unable to stimulate T-cell as compared to transfection with wild type form [11]. The above
observations clearly indicated that conformation of transmembrane MHC-II protein is gov-
erned by the binding of membrane cholesterol through its CRAC motif. Thus, altered
Conformational Change of MHC-II in Leishmania donovani Infection
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0004710 May 23, 2016 3 / 23
conformation of MHC-II protein in the absence of appropriate interaction with membrane
cholesterol led to concomitant decrease in the affinity of cognate peptide towards MHC-II pro-
tein and resulting in defective T-cell stimulating ability [11].
Since LD infected macrophages show decrease in membrane cholesterol, we endeavored of
studying the kinetics parameters of peptide-MHC interaction in normal, LD-infected and lipo-
somal cholesterol/cholesterol analogue treated LD-infected host cell. To gain further insight
how membrane cholesterol may influence conformation of MHC-II protein, we performed all
atom molecular dynamics (MD) simulation (1 μs each) with cholesterol bound (277314 atoms)
and free MHC-II (330636 atoms) proteins embedded in 1-palmitoyl-2-oleoyl-sn-glycero-
3-phosphocholine (POPC) bilayer. We used POPC membrane system in order to mimic over-
all physiological setup [19]. Structural adaptations and flexibilities within the peptide binding
domain (PBD), middle domain and the transmembrane (TM) region were compared with
respect to presence and absence of bound cholesterol. Our results suggest that the binding of
cholesterol at the TM domain alters the inherent flexibility of the MHC-II structure and proba-
bly helps in maintaining the appropriate volume and distance of the peptidyl antigen binding
pocket. Our findings extrapolated from the MD simulation data indicate that LD proteins may
manipulate T-cell stimulating ability of the infected macrophages by altering conformation of
MHC-II protein. To our knowledge this is the first experimental demonstration to show that
intracellular L. donovani by decreasing membrane cholesterol may influence the kinetic
parameters of peptide-MHC complex formation and may contribute to the defective cellular
immunity in leishmaniasis and restoration of membrane cholesterol may reverse the process.
Materials and Methods
Ethics statement
Use of mice was approved by the Institutional Animal Ethics Committee of CSIR-Indian Insti-
tute of Chemical Biology, India. All animal experimentations were performed according to the
National Regulatory Guidelines issued by CPSEA (Committee for the Purpose of Supervision
of Experiments on Animals), Ministry of Environment and Forest, Govt. of India.
Abs and other reagents
FBS, Penicillin-streptomycin, sodium bicarbonate, HEPES, 2-ME, 1,6-diphenyl-1,3,5-hexa-
triene (DPH), starch, cholesterol, RPMI-1640, Medium199 (M199), Giemsa and HEL (Hen
Egg Lysozyme) was purchased from Sigma Aldrich (St. Louis, MO). Methanol purchased from
Merck (Germany). Phosphatidylcholine (PC), 4-cholestene-3-one (cholesterol analogue), and
DPPC (1,2-dipalmitoyl-sn-glycero-3-phosphocholine) was purchased from Avanti polar lipid
Inc., (Alabaster, Alabama). ELISA assay kit for IL-2 assay was purchased from BD Bioscience
(San Diego, CA). FITC conjugated mAb 11–5.2 purchased from Biolegend, San Diego. B cell
hybridoma that produces mAb 10–2.16 was purchased from ATCC. m2C44 cell line, specifi-
cally recognized LACK156-173-major histocompatibility complex class II of H-2
d (Ad) complex,
was a gift from Prof. Eveylene Mougneau (Institut de Pharmacologie Moléculaire et Cellulaire,
INSERM U924, Valbonne, France). Amino acid residues 156–173 (ICFSPSLEH-
PIVVSGSWDR) of LACK protein (defined as LACK156–173, Ad restricted) was synthesized
using standard FMOC chemistry as described previously [6].
T cell hybridoma
HyH12.6 (Ak restricted), specific for hen egg lysozyme (HEL) was gift from Prof. Peter Wal-
den (Humbolt University, Charite’, Berlin, Germany) and LMR7.5 (Ad restricted), specific
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for 156–173 sequence of Leishmania homolog of receptors for activated C-kinase
(LACK156-173 peptide) was gift from Prof. Eveylene Mougneau (Institut de Pharmacologie
Moléculaire et Cellulaire, INSERM U924, Valbonne, France). The cell line was maintained in
RPMI-1640 medium supplemented with 10% FCS and 2-ME (5 x 10−5 M) at 37°C with 5%
CO2 in a humidified atmosphere.
Monoclonal antibodies
The mAb 11–5.2 (IgG2b,k) recognize Ia.2 epitope binds close to the peptide binding groove of
MHC II α chain where arginine-57 and glutamine-75 are critical for binding [20, 21]. Ia.2 is a
conformational specific epitope whose expression depends on the presence of specific MHC II
β chain [22] and the interaction with transmembrane domain of MHC II [23, 24]. mAb 10–
2.16 recognizes β-chain of Ak [24].
Animals
Balb/c mice were obtained from the animal facility of the institute and CBA/j mice were pro-
cured from National Institute of Immunology (New Delhi, India). Animals were used for
experimental purposes with prior approval of the institutional animal ethics committee. Mice
were housed under conventional conditions, with food and water adllibitum.
Parasite maintenance
Leishmania donovani (LD) strain AG83 (MHOM/IN/1983/AG83), originally obtained from
Indian kala-azar patients, was maintained in Golden Hamsters as described previously [4].
Promastigotes obtained after transforming amastigotes from spleen of infected animals were
maintained in culture M199 supplemented with 10% FCS at 22°C. The culture was replenished
with fresh medium every 72–96 h.
Isolation of peritoneal exudate cells (PEC)
CBA/j and Balb/c (8–10 weeks old) mice were intraperitoneally injected with 3 ml of 4% starch.
After 48 h PEC were isolated and plated on tissue culture petri dishes (1×106cells/ml) or glass
cover slip (1×105/ml), in 10 ml or 0.5 ml respectively in complete RPMI medium for 48 h at
37°C in humified 5% CO2 incubator. Non-adherent cells were removed thereafter by gentle
washing with serum free medium. The PECs, determined on the basis of positive staining with
FITC CD11b, were ~95% CD11b+ [6]. For convenience, adherent PECs are defined as macro-
phage (MF) henceforth. Previous study showed that these are resting MF [25, 26].
Generation of bone marrow derived of dendritic cell (DC)
Bone marrow-derived dendritic cells of Balb/c (BM-DC) were generated as described [27].
Briefly, A total of 106 nonadherent bone marrow cells/ml, collected from the tibias and femurs
of BALB/c mice, were seeded in a 6-well plate in the presence of rmGM-CSF (150 U/ml) and
rmIL-4 (75 U/ml) and then cultured for 72 h at 37°C in humified 5% CO2 incubator and then
supplemented with complete medium and cytokines, and subsequently cultures were fed with
rmGM-CSF and rmIL-4 on days 5. After 7 days, the cells were collected. Then 2 х 106 cells
were transferred in a 6 well plate. The DC were used as antigen presenting cells (APCs).
Infection of MΦ/DC with LD
Stationary phase promastigotes were used for in vitro infection of MFs/DC (derived from
Balb/c). The MFs/DC after overnight incubation in complete medium, were challenged with
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LD promastigotes (macrophage/DC to parasite ratio 1:10) and incubated further for 6 h at
37°C. Excess parasites were then washed off with serum free medium. The MFs/DC were then
incubated further for 48 h and intracellular parasites were enumerated as described previously
[28]. Briefly, at endpoints the cover slips were washed with PBS, microscopically and the results
were expressed as % infected as well as the number of parasites/ 100 MF, dried, fixed with
100% methanol and stained with 10% Giemsa. It was observed that at 6 h average parasite/ cell
was 5 and 48 h average parasite/ cell was 11 (S1 Fig). 85–90% of MFs were infected MFs.
Liposome preparation and treatment
Liposomal cholesterol or liposomal cholesterol analogue were prepared either with cholesterol
or cholesterol analogue (4-cholestene-3-one) and phosphatidyl-choline at a molar ratio of 1.5:1
as previously described [5]. DPPC liposome was prepared as described in [7]. To alter the fluid-
ity of cells, 105 cell /100μl were incubated with 10 μl liposomes for 20 h at 37°C. The cells were
then washed three times in serum-free RPMI 1640 medium and finally resuspended in 10%
FCS containing RPMI 1640.
Measurement of fluorescence anisotropy (FA)
The membrane fluidity of cells was measured following the method described by Shinitzky
et al. [29]. Briefly, the fluorescent probe DPH was dissolved in tetrahydrofuran at 2 mM con-
centration. To 10 ml of rapidly stirring PBS (pH 7.2), 2 mMDPH solution was added. For
labeling, 106 cells were mixed with an equal volume of DPH in PBS (Cf 1 μM) and incubated
for 2 h at 37°C. Thereafter the cells were washed thrice and resuspended in PBS. The DPH
probe bound to the cellular membrane was excited at 365 nm and the intensity of emission was
recorded at 430 nm in a spectrofluorometer. The FA value was calculated using the equation:
FA = [(III−(G×II)]/ [III +(2×G×II)], where III and II are the fluorescent intensities oriented par-
allel and perpendicular to the direction of polarization of the excited light.
Stimulation of T cell hybridoma in the context of antigen presenting cells
(APCs) and peptide/protein
The ability of normal MF (N-MF), infected MF (I-MF), infected MF treated with liposomal
cholesterol (I-MF-CL), infected MF treated with liposomal cholesterol analogue (I-MF-AL),
infected MF treated with liposomal DPPC (I-MF-DPPC) and normal MF treated with lipo-
somal cholesterol (N-MF-CL) were used as APCs to stimulate anti-HEL T cell hybridoma
(HyH12.6) and anti-LACK T cell hybridoma (LMR 7.5) in the presence of HEL protein and
LACK156-173 peptide respectively. Briefly, 5×10
5 T cell hybridomas were cocultured with 1X105
appropriate MFs in the presence of respective antigen. Both T cell and MFs were kept for 24 h
in complete medium at 37°C in humified 5% CO2. The resulting culture supernatant was
assayed for IL-2 by ELISA.
Analysis peptide-MHC stability on cells surface using FACS
Since mAb, m2C44 recognizes LACK156-173-A
d [30] the peptide-MHC stability was studied in
MF derived from Balb/c mice. MFs were pulsed with 20 μM LACK156-173 peptide for 6 h at
37°C followed by washing and then fixed with 4% paraformaldehyde followed by washing (this
is defined as ‘0’ h). We have studied the stability of the peptide-MHC complex in the peptide
pulsed fixed MF as described by others [31, 32]. Then the cells were incubated with 50 μM
OVA323-339 (A
d restricted) in order to prevent rebinding of the dissociated LACK156-173 peptide
[33, 34]. The cells were incubated with 400 μl of m2C44 culture supernatant for 1 h followed
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by stained with goat anti-mouse IgG FITC as described [30]. MFI of 5000 cells were measured
at 0, 2, 4, 8 and 12 h.
Functional analysis of peptide-MHC stability
MFs were pulsed with 20 μM LACK156-173 for 6 h at 37°C [34] and then fixed with 4% parafor-
maldehyde followed by washing (this is defined as ‘0’ h) and incubated with 50 μM
OVA323-339. Then the cells were cocultured with T cell hybridoma (LMR7.5) at 0, 2, 4, 8, 12
and 24 h. The resulting IL-2 production in the supernatant was measured by ELISA [4].
Cell surface expression of MHC-II
Conformation specific mAb is available for H-2k haplotype (11–5.2) recognize Ia.2 epitope but
not for H-2d, therefore conformational change of MHC-II protein was studied in MF derived
from CBA/j mice. Ia.2 epitope expression was measured using FITC label mAb 11-.5.2. The
total cell surface expressions of MHC-II were measured by anti-mouse Ak (10–2.16) [24]. The
cells were stained with goat anti-mouse FITC in PBS containing 5% FCS. The MFI for FITC
was determined in a FACS ARIA-II system (BD Bioscience, San Diego, CA).
Molecular dynamics simulation system
Molecular dynamics (MD) simulations of the MHC-II embedded in 1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphocholine (POPC) membranes were carried out in the presence and absence
of cholesterol using GROMACS 4.6.1 [35]. The chemical structure of POPC and cholesterol is
shown in S2 Fig. In our previous study, X-ray coordinates of MHC-II protein extracellular
domain structure [PDB ID: 2IAD] was attached with computational model of TM domain
using Modeler v9.9 [11]. The full length MHC-II model was validated extensively and utilized
in molecular docking of cholesterol to the CRAC motifs of MHC-II protein [11]. In the same
study, experimental validation of the predicted binding sites further added support to the reli-
ability of the three-dimensional (3D) model [11]. Hence, in this study, same 3D models of
MHC-II with bound and unbound cholesterol [11] were utilized to understand the effect of
cholesterol on peptide binding. POPC bilayer was created with 512 POPC molecules and for
uniform distribution of POPC, the bilayer was equilibrated for 60 nano seconds (ns). Docked
MHC-II-cholesterol was inserted into the equilibrated POPC bilayer using the GROMACS
g_membed tool (S2 Fig) [36]. All the systems were solvated with SPC (simple point charge)
waters [37] and system-neutralizing sodium ions were added. GROMOS96 53A6 force field
[38] was used for all the molecules. Size, duration, and other relevant details regarding the sim-
ulation runs are provided in Table 1. Super-computing facility located at CSIR-fourth
Table 1. Summary of MD simulations.
Run no. System size (atoms) Duration of simulation No. of POPC molecule No. of water bead No. of CHL
With CHL 1 277314 1μs 489 82290 2
With CHL 2 277314 1μs 489 82290 2
With CHL 3 277314 1μs 489 82290 2
Without CHL 1 330636 1μs 490 100066 0
Without CHL 2 330636 1μs 490 100066 0
Without CHL 3 330636 1μs 490 100066 0
Details of simulations performed with and without cholesterol (CHL) systems.
doi:10.1371/journal.pntd.0004710.t001
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paradigm institute, Bangaluru, India, was utilized to perform 1μs-scale simulations of MHC-II-
cholesterol system comprising of approximately 3 lakhs atoms.
Simulation conditions
In all simulations, a leap-frog integrator [39] was used with a 2 fs time step. Periodic boundary
conditions together with the usual minimum image convention were used in all three direc-
tions. To remove steric clashes and to avoid drastic rearrangement during setup, all the systems
were energy-minimized using steepest descent, conjugate gradient and positional restraint
methods. All covalent bonds in the system were constrained to their equilibrium values with
the LINCS algorithm [40].
Cutoff radius of 12 Å was employed for van der Waals and electrostatics interactions. The
particle-mesh Ewald (PME) algorithm [41] was applied to treat long-range electrostatic interac-
tions. The update of the neighbor list for short-range non-bonded interactions was done every
10 MD steps. The temperature for each group was coupled using the Nose-Hoover thermostat
algorithm [42] with a coupling constant of 2.5 ps to maintain a constant temperature of 300K
during simulation. Semi-isotropic pressure was maintained using the Parrinello-Rahman algo-
rithm [43] with a pressure of 1 bar independently in the plane of the membrane and perpendicu-
lar to the membrane, a coupling constant of 5 ps, and a compressibility of 4.5e-5. The 3 MD runs
(see Table 1 for more detail) of 1μs each (with and without cholesterol system) were taken for cal-
culating the averages. The atomic coordinates were saved at every 2 ps for the analyses. GRO-
MACS tools were used to do analyses of the trajectories generated from the MD simulations. A
cholesterol molecule was defined to be bound to a particular transmembrane helix or amino acid
residue (site) of MHC-II if it was within 0.5 nm of the previously described binding sites [11].
The calculations of root mean square deviation (RMSD) and root mean square fluctuation
(RMSF) were made with respect to the starting structure. The time dependent change of the
solvation area was calculated using g_sas whereas the helicity was estimated by the g_helix
module of GROMACS. Tilt and twist of the helices were calculated using the g_helixorient.
ProDy [44] was used to calculate the all-to-all cross-correlation of fluctuation within the
MHC-II molecule. Mean correlation was calculated by averaging the correlation of fluctuation
between any two residues from the three independent simulation runs.
Results
Restoration of membrane fluidity of infected macrophages by liposomal
forms of cholesterol or DPPC but not by cholesterol analogue
The MF from CBA/j mice were infected with LD (I-MF) and treated with liposomal choles-
terol (I-MF-CL) or liposomal cholesterol analogue (I-MF-AL) or liposomal DPPC (I-MF-
DPPC). Similarly, normal MF (N-MF) were also treated with liposomal cholesterol (N-MF-
CL). The membrane fluidity of N-MF, I-MF, I-MF-CL, I-MF-AL, I-MF-DPPC and N-MF-
CL was measured in terms of fluorescence anisotropy (FA) using DPH as a fluorescence probe.
It was observed that there was significant decreased in FA in I-MF which was restored to nor-
mal in I-MF-CL and 1-MF-DPPC but not in I-MF-AL. Interestingly in N-MF-CL insignifi-
cant change in FA values compared to untreated control MF (Fig 1A).
Only liposomal cholesterol treatment restored T-cell stimulating ability of
infected macrophages/ dendritic cells
MF/DC from Balb/c (H-2d) and CBA/j (H-2k) were used as antigen presenting cells (APCs) to
stimulate respective MHC-II restricted T-cell hybridomas, HyH12.6 (Ak restricted) and
Conformational Change of MHC-II in Leishmania donovani Infection
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0004710 May 23, 2016 8 / 23
LMR7.5 (Ad restricted). The IL-2 production from T-cell hybridomas in the presence of appro-
priate APCs and antigens was used as a functional read out of T-cell activation. It was observed
that T-cell stimulating ability of I-MF of Balb/c or CBA/j origin was decreased by 6 to 7 fold
as compared to N-MF (Fig 1B and 1C). Furthermore, only liposomal cholesterol treatment of
I-MF restored the APC function to normal regardless of the source of MF. On the other hand,
cholesterol analogue liposome or DPPC liposome treatment of I-MF failed to show any further
improvement in their ability to stimulate T-cell. Interestingly enough, DPPC liposome treat-
ment of I-MF restored the membrane fluidity but not their APC function (Fig 1B and 1C). It
was observed that LACK protein and LACK peptide (LACK156-173) showed similar results in
terms of T cell response (Fig 1D).
Fig 1. Determination of membrane fluidity in terms of Fluorescence Anisotropy (FA) and T cell stimulating ability of normal, infected and
liposome treated infected MΦ. A, The FA (Fluorescence Anisotropy) of normal MΦ (N-MΦ), infected MΦ (I-MΦ), infected MΦ treated with liposomal
cholesterol (I-MΦ-CL), infected MΦ treated with liposomal cholesterol analogue (I-MΦ-AL), infected MΦ treated with liposomal DPPC (I-MΦ-DPPC) and
normal MΦ treated with liposomal cholesterol (N-MΦ-CL) was measured using DPH as a probe. The fluorophore was excited at 365 nm, emission
intensity was recorded at 430 nm and FA was calculated as described in the materials and methods.B, anti-HEL T cell hybridoma (HyH12.6, Ak
restricted) were cocultured with N-MΦ, I-MΦ, I-MΦ-CL, I-MΦ-AL, I-MΦ-DPPC and N-MΦ-CL in presence of 15 μMHEL protein. For stimulation of
HyH12.6, MΦs were derived from CBA/j mice. C, anti-LACK T cell hybridoma (LMR7.5, Ad restricted) were cocultured with N-MΦ, I-MΦ, I-MΦ-CL, I-MΦ-
AL, I-MΦ-DPPC and N-MΦ-CL in presence of 5 μM LACK protein. For stimulation of LMR7.5, MΦs were derived from Balb/c mice.D, anti-LACK T cell
hybridoma (LMR7.5) were cocultured with N-MΦ, I-MΦ, I-MΦ-CL, I-MΦ-AL, I-MΦ-DPPC and N-MΦ-CL in presence of 5 μM LACK156-173 peptide. The
resulting IL-2 production in the culture supernatant was assayed by ELISA as a read out of T-cell stimulation.
doi:10.1371/journal.pntd.0004710.g001
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Similarly, I-DC were unable to stimulate T cell hybridoma (LMR7.5). Only, liposomal cho-
lesterol treatment of I-DC (I-DC-CL) can restore APC function not by others treatment such
as liposomal cholesterol analogue or liposomal DPPC (S3 Fig).
Decreased binding of conformation (11–5.2) but non-conformation
(10.2.16) specific anti Ak mAb to I-MΦ corrected by liposomal cholesterol
treatment
Because of the availability of the conformation specific anti Ak mAb (11–5.2) such studies were
carried out with MF of CBA/j origin. The binding ability of two different anti Ak mAb was
studied in N-MF, I-MF, I-MF-CL. The binding was monitored in terms of fluorescence inten-
sity and results were expressed as MFI. It was observed that the binding of 11–5.2 was
decreased by about 60% in I-MF as compared to N-MF whereas binding of non-conformation
specific antibody (10–2.16) remain unaltered. Similar trend was maintained in I-MF-AL and
I-MF-DPPC. However the binding of 11–5.2 was restored to normal in I-MF-CL (Fig 2).
Altered stability of MHC-II in absence of bound cholesterol
Molecular dynamic simulation was carried out using a three-dimensional (3D) model of full
length MHC-II dimer structure [11] docked with cholesterol. Structural stability of the
MHC-II in presence and absence of cholesterol was investigated based on properties such as
Fig 2. LD infection show reduced binding of conformational antibody but not non-conformational antibody.
The binding of mAb 11–5.2 (conformational antibody) to N-MΦ, I-MΦ, I-MΦ-CL, I-MΦ-AL and I-MΦ-DPPC was
determined to assess cell surface expression of Ia.2 epitope (filled bar). The cells were stained with FITC conjugate
mAb 11–5.2. Similarly binding of mAb 10–2.16 (non-conformational antibody) to N-MΦ, I-MΦ, I-MΦ-CL, I-MΦ-AL and
I-MΦ-DPPC was determined to assess total expression of Ak (blank bar). The cells were stained with mAb 10–2.16
followed by FITC conjugated goat anti mouse IgG. The binding was expressed in terms of MFI. *** represents
p<0.0005, ns represent non-significant.
doi:10.1371/journal.pntd.0004710.g002
Conformational Change of MHC-II in Leishmania donovani Infection
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0004710 May 23, 2016 10 / 23
root mean square deviation (RMSD) and root mean square fluctuation (RMSF) of the full
length MHC-II and the bound peptide. The RMSD is the average displacement of the atoms at
an instant of the simulation relative to the first frame of the simulation. The RMSD of MHC-II
in presence of cholesterol was increased from ~1Å to ~7Å and remained stable especially for
the last 200ns), but in absence of cholesterol it increased from ~1Å to ~8Å and did not stabilize
even after 900 ns (S4A Fig). This suggests that the relatively higher stability observed within
the cholesterol bound MHC-II structures is perhaps due to the cholesterol binding. Similarly,
RMSD of the peptide (S4B Fig) remains slightly higher in absence of bound cholesterol. The
flexibility of each residue can be inferred from its RMSF values. S5A Fig shows the RMSF for
MHC-II chains and domains whereas panel S3B provides the same for peptide in presence and
absence of bound cholesterol. The average fluctuations of the residues in both chains of
MHC-II were relatively higher for simulation performed without the bound cholesterol (S5A
and S6 Figs). Similarly, significantly higher fluctuations within the peptide were also observed
for simulation performed without the bound cholesterol (S5B Fig).
Structural changes within the peptide binding domain in absence of
bound cholesterol
Peptide binding domain (PBD) of MHC-II is responsible of binding and presenting the anti-
genic peptide to the T-cell receptor to initiate the immune response. Hence, structural alter-
ation in this domain might lead to loss of peptide binding and/or presentation of peptide to T
cells. Structural changes (e.g., RMSD and percentage helicity) were observed within the PBD
helices with respect to presence and absence of the bound cholesterol (Fig 3). Similarly, accessi-
ble surface area (ASA) of the PBD was also found to be increased in absence of bound choles-
terol (Fig 4A). This could be due to the higher inter-helix and helix-peptide distances observed
in absence of bound cholesterol (Fig 4B, 4C and 4D) resulting in reduced peptide binding.
Structural changes within the middle domain in absence of bound
cholesterol
MHC-II middle domain (MID) comprised of immunoglobulin like folds, showed significant
difference in fluctuation with respect to presence and absence of bound cholesterol (S5 and S6
Figs). RMSD pattern (S7 Fig) of the domain in presence and absence of cholesterol also showed
significance variation. This is interesting as the middle domain usually acts as a connector
between TM and the PBD and significant alterations in middle domain conformation and flex-
ibility advocate its role in maintaining the structural stability of the extracellular domains with
respect to cholesterol binding at the TM region.
Structural changes within the TM regions in absence of bound
cholesterol
The tilt and twist of the TM helices are altered markedly with respect to presence and absence
of bound cholesterol (Fig 5). Frequencies of residues in helical conformation were calculated
from the ensemble TM structures. Similarly, variations in typical intra-helix (i+i4th residue)
hydrogen bond length were measured for the TM helices. It is clear from S8A and S8B Fig that
chance of a residue to be present in helical conformation is higher for TM region chain A than
chain B in presence of bound cholesterol, however, the typical hydrogen bond lengths were not
significantly altered (S8C and S8D Fig).
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Cross-correlation of structural fluctuation between MHC-II domains
Striking structural fluctuations were observed within the domains of MHC-II in presence and
absence of bound cholesterol. However, it is interesting to investigate whether the fluctuations
are correlated between the domains and whether binding of cholesterol impacts these correla-
tions. Hence, cross-correlation or covariance of fluctuation among all residues and domains
were calculated and are represented in terms of matrices (S9 Fig) and S1 Table, respectively. S10
Fig suggests that the cholesterol binding probably impacts the cross-correlation between various
domains of MHC-II protein as majority of the cases the fold changes of cross-correlation are
found to be more than unity in cholesterol bound form compared to the unbound form.
Energetic changes within the MHC-II in absence of bound cholesterol
As the stability of the MHC-II is closely related to its energetics, the solvation free energies
(Kcal/Mol) of the PBD and the bound peptide were calculated using PDBePISA [45] for a few
Fig 3. Alteration in overall structure and the helicity of the peptide binding domain (PBD). Panel A
provides RMSD trajectories of the PBD extracted from the simulations with (dark grey) and without (light grey)
the docked cholesterol. Panel B and C provide the plots where percentages of residues in α-helix conformation
are plotted against the simulation time for chain A PBD helix (residues: 50–80) and Chain B PBD helix
(residues: 52–89), respectively. White and black lines represent moving averages (period: 10) of the raw data.
doi:10.1371/journal.pntd.0004710.g003
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selected ensemble structures extracted at various time points of the simulation and were com-
pared with respect to presence and absence of bound cholesterol. Interestingly, significant
reductions in energies were observed for most of the complexes (PBD and peptide) extracted in
absence of bound cholesterol (Fig 6). This exercise clearly indicates that the presence of choles-
terol indeed impacts the peptide binding energetics at the PBD. However, more detailed and
exhaustive study is required for in depth understanding of the energetic changes.
Assay of kinetic stability using mAB that recognize peptide-MHC
complex
Because of the availability of leishmanial antigen, LACK specific T-cell hybridoma (LMR7.5) of
Balb/c origin and mAb that recognize LACK156-173-A
d (m2C44), the kinetic parameters of pep-
tide-MHC stability was studied with APCs of Balb/c origin. The stability of peptide-MHC
Fig 4. Alteration in the volume and size of the peptide binding pocket. Solvent accessible surface area
(SASA) values of the peptide binding region are plotted against the simulation time (panel A). Light grey line
represents for without cholesterol runs whereas dark grey line represents SASA values extracted from
simulation performed with the docked cholesterol. White and black lines show running average of 10 points.
Panel B plots the distance (nm) between two helices of PBD whereas panel C and D shows the average
distance between the peptide and the chain A PBD helix and chain B PBD helix, respectively. White and black
lines represent moving averages (period: 10) of the raw data.
doi:10.1371/journal.pntd.0004710.g004
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complex was monitored by looking at the availability of peptide-MHC complex on the surface
and also by their ability to stimulate appropriate T-cells. The availability of LACK156-173-A
d
was monitored using fluorescence labeled antibodies. It was observed that at ‘0’h time point the
MFI in I-MF was 30% less as compared to N-MF. The identical results were observed in the
case of I-MF-AL. Interestingly, the results were superimposable between N-MF and I-MF-
CL. The rate of dissociation of the peptide-MHC complex in N-MF and I-MF and I-MF-CL
and I-MF-AL was 1.45μs-1, 16.3μs-1, 1.68μs-1 and 13.4μs-1, respectively (Fig 7A).
Functional assay of kinetic stability of peptide-MHC complex in terms of
T-cell activation
We also assessed the availability of LACK156-173-A
d complex on the cell surfaces of MF on the
basis of their ability to stimulate anti-LACK T cell hybridoma (LMR7.5). The T cell stimulating
ability was measured in terms of IL-2 production. It was observed at ‘0’ h time point the IL-2
production from LMR7.5 was ~ 40% less when I-MF or I-MF-AL were used as APCs as
Fig 5. Structural alteration in TM domain with respect to presence and absence of cholesterol. Twist
(panel A and B) and tilt (panel C and D) of the TM helices calculated with respect to presence and absence of
docked cholesterol are plotted against simulation time. Dark and light grey lines represent average twist and
tilt values of TM helices extracted in presence and absence of docked cholesterol.
doi:10.1371/journal.pntd.0004710.g005
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compared to N-MF or I-MF-CL. The rate of decreases of IL-2 production in I-MF and I-MF-
AL was 17.1 μs-1 and 15.8 μs-1 respectively whereas the same for N-MF and I-MF-CL were
1.29 μs-1 and 1.38 μs-1 respectively (Fig 7B).
Discussion
In this investigation we endeavored to learn the ‘complex rules’ of how intracellular LD para-
sites escape the immune surveillance of the host. The basic tenet of this investigation is based
on our past studies where we showed that LD parasites during their intracellular life cycle in
MF of Balb/c origin take up membrane cholesterol leading to an increase in membrane fluidity
[5]. Cholesterol is the major component of eukaryotic bio-membrane and plays a central role
in the process of signal transductions [46], maintenance of membrane fluidity [9] and trans-
port [47]. Kala azar patients show dramatic decrease in serum cholesterol as a function of
splenic parasite load [48]. Previously, we unveiled the mechanism of hypocholesterolaemia in
experimental LD infection and showed that maturation of miR122 in the liver is inhibited via
GP63 mediated cleavage of DICER1 [8] and statin induced hypocholesterolaemia show higher
organ parasites in experimental infection than the ones without treatment [49]. Here we show
that similar to I-MF of Balb/c mice [4, 5], I-MF of CBA/j mice also showed increased mem-
brane fluidity coupled with defective T-cell stimulating ability and such attributes of I-MF can
be corrected by liposomal cholesterol but not by liposomal cholesterol analogue or liposomal
DPPC. To show that cholesterol mediated effect is specific to I-MF, N-MF were treated with
liposomal cholesterol and such treatment showed hardly any additional effect (Fig 1) indicating
that liposomal cholesterol has specific effects on the I-MF. Like I-MFs, LD infected dendritic
cell (DC) also showed defective T cell stimulation and treatment with liposomal cholesterol
restored T cell stimulating ability (S3 Fig). Liposomal DPPC delivery despite restoring mem-
brane rigidity as shown earlier [50, 51] failed to restore T cell stimulating ability of I-MF (Fig
1) suggesting that: a) correction of membrane fluidity of I-MF is not enough to stimulate T cell
and b) there is a specific need for cholesterol.
Fig 6. Change in peptide binding energy in PBDwith respect to presence and absence of cholesterol.
Solvation free energies (Kcal/Mol) of the PBD domain and the bound peptide for a few selected ensemble
structures extracted at various time points [from 0NS (nanosecond) to 1MS (microsecond)] are shown. Dark
and light grey bars represent complexes extracted from the simulation performed in presence and absence of
bound cholesterol, respectively.
doi:10.1371/journal.pntd.0004710.g006
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Fig 7. Dissociation of peptide-MHC-II complex on the live cells.N-MΦ (red), I-MΦ (green), I-MΦ-CL
(blue) and I-MΦ-AL (black) were pulsed with 20 μM LACK156-173 peptide for 6 h at 37°C and this is defined as
‘0’ h time point, followed by washing and then fixed with 4% paraformaldehyde followed by washing and
incubated with 50 μMOVA323-339. A, LACK156-173-A
d dissociation was measured by FACS. The presence of
LACK156-173-A
d was monitored at 0, 2, 4, 8, and 12 h time points. The cells was stain with m2C44 followed by
staining with goat anti-mouse IgG FITC. The data are plotted as the ratio [MP]/[MP0] vs time (h). [MP] is MFI
at a given time and [MP0] is MFI of N-MΦ at 0 h time (time point after 6 h of pulsing).B, LACK156-173-A
d
dissociation was monitored by the ability of the complex in the context of appropriate APCs to stimulate T-
cells. The presence of LACK156-173-A
d was monitored by coculturing anti-LACK T cell hybridoma (LMR7.5)
with peptide pulsed APCs and the resulting IL-2 production in the supernatant was measured at 0, 2, 4, 8 and
12 h. The data are plotted as the ratio [IL-2]/[IL-20] vs time (h). [IL-2] is the IL-2 produced at a given time and
[IL-20] is the IL-2 produced from N-MΦ at 0 h time. The rate of dissociation (koff) was calculated by
considering 1st order dissociation.
doi:10.1371/journal.pntd.0004710.g007
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Cholesterol’s effects are also possibly due to specific sterol-protein interactions, as shown in
the case of a number of membrane bound receptors, such as those for oxytocin, cholecystoki-
nin, galanin and nicotinic acetylcholine [16]. Molecular dynamics (MD) studies revealed that
cholesterol physically interacts with nicotinic acetylcholine receptor to prevent the structure
from distortion and collapse [52]. Previously, we showed using that transmembrane domain of
MHC-II (TM-MHC-II) interacts with cholesterol through CRAC like motifs to bring about
conformation change of MHC-II protein [11]. It has been shown through MD studies that cho-
lesterol interacts with rhodopsin to induce local structural perturbation, which in turn brings
global conformational rearrangements through rigid body motion [53]. In this study we have
investigated how interaction of cholesterol with TM-MHC-II would influence conformation
changes in the distal peptide binding groove of the MHC-II protein. The availability of confor-
mation and non-conformation specific anti Ak mAb greatly aided in such investigation. The
anti Ak mAb 11–5.2 recognizes Ia.2 epitope and binds close to the peptide binding groove of
MHC-II α chain where arginine-57 and glutamine-75 are critical for binding [20, 21]. Ia.2 is a
conformational specific epitope and its expression depends on the presence of specific MHC-II
β chain [22]. Recent study from our group [11] and by others [24] showed that conformation
change of Ak can be monitored by mAb 11–5.2. These studies reinforce that Ia.2 is a conforma-
tional epitope and mAb 11–5.2 is a tool to monitor the conformational change in Ak. We
showed that binding of 11–5.2 to I-MF was reduced by about 60% as compared to N-MF
whereas binding of 10–2.16 was comparable between N-MF and I-MF. This observation indi-
cated that Ak molecules are on the surface of I-MF, where conformational constrains may
limit the binding of 11–5.2 to I-MF but not to I-MF-CL. This effect was cholesterol specific
because the binding of 11–5.2 with I-MF was not restored by cholesterol analogue liposome or
DPPC liposome treatment.
Here, we also performed exhaustive molecular dynamic simulations to study the effect of
cholesterol binding on the TM-MHC-II domain to the distal mid domain and peptide binding
groove of MHC-II. Our MD analyses and results suggest marked variations in flexibility and
conformational adaptability of the MHC-II protein with respect to cholesterol binding. Our
results also provide insight towards the mechanistic details of the probable long range allosteric
adaptation observed at MHC-II extracellular domain with respect to binding of cholesterol at
the lower base of the TM domain. Local alterations such as tilt and twist of the TM helices vary
noticeably with and without the bound cholesterol. Our cross-correlation of flexibility analyses
suggest that these changes at the TM-MHC II domain are probably correlated with the confor-
mational variation at the distal extracellular domain. Further, peptide binding energetics was
found to be favorable in presence of bound cholesterol indicating stability of peptide-MHC II
complex may reduce in absence of cholesterol. To test the prediction that peptide-MHC II sta-
bility is compromised in absence of cholesterol we measured peptide-MHC II stability on the
cell surface. The stability of peptide-MHC II complex on the cell surface can be measured by
two methods: 1) APC was pulsed with peptide followed by fixation (with either glutaraldehyde
or paraformaldehyde) and 2) APC was fixed followed by pulsed with peptide [31, 32]. It has
been shown that under both experimental conditions stability of peptide-MHC complex is
identical therefore fixation of the peptide doesn’t have detrimental effect on the peptide-MHC
stability. Here we adopted method 1 and our experimental studies on the kinetic stability of the
peptide-MHC complex it was clear that the rate of dissociation of the cognate peptide from the
complex was 1.45, 16.3, 13.4 and 1.68 μs-1 in N-MF, I-MF, I-MF-AL and I-MF-CL, respec-
tively and this was further validated from the progressive decrease in IL-2 production in anti-
LACK T-cells as a function of time. This observation shows a clear association between
reduced binding of 11–5.2 to cell surface Ak and faster dissociation of cognate peptide from
peptide-MHC complex in I-MF. The above defects were found to be corrected by liposomal
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cholesterol treatment of I-MF. On the basis of our computational data supported by experi-
mental findings, we tend to believe that interactions of cholesterol with TM-MHC-II may allo-
sterically modify the conformation of peptide binding groove and this leads to more
stabilization of the peptide-MHC complex on the cell surface under physiological condition
than pathological condition. Earlier MD based studies involving serotonin 1A [54, 55] and β2
adrenergic receptors [56] have shown that enrichment of cholesterol within the membrane
alters protein oligomerization and stability. Hence, in case of MHC-II, impact of both the
bound and membrane enriching cholesterol should be studied to simulate more realistic bio-
logical scenario. However, all-atom and/or coarse grain simulations using such systems are out
of the scope of this current work and will be addressed in our future studies. The modulation of
cholesterol induced conformation change of membrane protein may be extremely complex
and have no simple technological (experimental) advances by which it is possible to monitor
the nature of changes that alter agonist affinity.
To support the MD study we showed that reduced peptide-MHC-II stability was restored to
normal by liposomal cholesterol treatment. Previously we showed that processing of exogenous
antigen and also the transport of peptide-MHC-II complex to the cell surface remains unal-
tered in LD infection [6].
Thus it is conceivable that the conformation of cell surface MHC-II in LD infection may be
a key, in part, to understand defective T cell response. There is a report that macrophages
from Balb/c mice upon infection with L. donovani show decrease in B7.1 expression whereas
ICAM1 expression is increased. It is not clear whether such effect was due to decrease in
membrane cholesterol. Thus all the membrane proteins are not equally affected in L. donovani
infection [57]. We also showed that in infected macrophages there is an increase in lateral
mobility of membrane protein [4] and such macrophages are incapable to form effective
immunological synapse with antigen specific T-cells [5]. Our study supported by a previous
observation by others in Leishmania major infection where it was shown that under heavily
parasitized condition the infected dendritic cells lack peptide-MHC-II (LACK156-173-A
d) com-
plex [30]. The present study is bringing a mechanistic view to explain how decrease in mem-
brane cholesterol in I-MFmay influence conformation of membrane associated protein like
MHC-II in this case. It may be recalled in this context that liposomal cholesterol shows dra-
matic therapeutic effect in experimental visceral leishmaniasis [5]. Beneficial role of choles-
terol has been noted from a number of epidemiological studies [58] and clinical studies in
pulmonary tuberculosis patients [59]. Patients with Smith-Lemli-Opitz syndrome who were
treated with a pure cholesterol suspension orally also showed improvement in symptoms
associated with the disease [60].
In summary, it appears that LD parasites by decreasing membrane cholesterol during their
intracellular life cycle may have altered the conformation of MHC-II molecules with direct
bearing on the compromised agonist affinity leading to faster dissociation of cognate peptide
from the peptide-MHC-II complex which could be corrected by liposomal cholesterol delivery.
Supporting Information
S1 Fig. Infection macrophages with LD. Stationary phase promastigotes were used for in vitro
infection of MFs. The MFs after 48 h incubation in complete medium, were challenged with
LD promastigotes (macrophage to parasite ratio 1:10) and incubated further for 6 h at 37°C.
Excess parasites were then washed off with serum free medium. The intracellular parasites
were enumerated microscopically at 6 h and 48 h after washing. The results were expressed as
the number of parasites/cell.
(TIF)
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S2 Fig. Three-dimensional (3D) model of MHC-II dimer along with the docked cholesterol
moieties.MHC-II molecule is embedded in POPC bilayer where chain A (red), chain B (cyan),
cholesterol (green) and peptide (yellow) are marked in different colors.
(TIF)
S3 Fig. Fold change of cross-correlation of fluctuation between MHC-II domains with
respect to presence and absence of cholesterol. N-DC, I-DC, I-DC-CL, I-DC-AL,
I-DC-DPPC and N-DC-CL were cocultured with anti-LACK T cell hybridoma (LMR7.5) in
presence of 5 μM LACK156-173 peptide. The resulting IL-2 production was measured by ELISA.
(TIF)
S4 Fig. Alteration in overall structure with respect to presence and absence of cholesterol.
Time evolution of root mean square deviation (RMSD) trajectory analysis of the MHC-II and
the bound peptide. Dark and light grey lines represent average RMSDs for MHC-II with and
without the docked cholesterol, respectively. Panel A provides RMSD trajectories for MHC-II
and the peptide whereas panel B shows trajectory for the peptide only.
(TIF)
S5 Fig. Alteration in residue fluctuation pattern with respect to presence and absence of
cholesterol. Root mean square fluctuations (RMSF) of MHC-II (panel A: chain A, chain B)
and peptide (panel B) residues were plotted with respect to the simulation time. Light grey
lines represent average RMSF for without cholesterol simulations while dark grey lines repre-
sent average RMSF for with cholesterol runs.
(TIF)
S6 Fig. Alteration in domain fluctuation pattern with respect to presence and absence of
cholesterol. Average RMSF of peptide binding domain (PBD), middle domain (MID) and
transmembrane domain (TM) are plotted with and without the docked cholesterols. PBD_A:
Peptide Binding Domain of Chain A; PBD_B: Peptide Binding Domain of Chain B; MID_A:
Middle Domain of Chain A; MID_B: Middle Domain of Chain B; TM_A: Transmembrane
Domain of Chain A; TM_B: Transmembrane Domain of Chain B.  denotes where p value
<< 0.001.
(TIF)
S7 Fig. RMSD of middle domain. Dark grey and light grey lines represent average RMSD of
MHC-II middle domain extracted from simulations performed with and without the docked
cholesterol.
(TIF)
S8 Fig. Alteration in helix properties of the TM helices. Frequencies of individual residues
located in α-helical conformation for chain A (panel A) and chain B (panel B) TM domains are
plotted against simulation time. Panel C and D plot the inter residue distances (of i and i+4th
residue) within the chain A (panel C) and chain B (panel D) TM helices. White and black lines
represent moving averages (period: 10) of the raw data.
(TIF)
S9 Fig. Covariance of residue fluctuation. Covariance or cross-correlation of fluctuation
between any pair of residues was calculated where higher correlation coefficient reflects higher
covariance. All-to-all matrices of the correlation coefficients are provided for MHC-II residues
when simulated with cholesterol (panel A, B, C representing correlation from three individual
simulation runs) and without cholesterol (panel D, E, F).
(TIF)
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S10 Fig. Fold change of cross-correlation of fluctuation between MHC-II domains with
respect to presence and absence of cholesterol. Fold change of cross-correlation of fluctua-
tion (FCACR = ACR+CHL / ACR-CHL) between various domains (Panel A: PBD domain and
TM domain; Panel B: MID domain and TM domain; Panel C: PBD domain and MID
domain) of MHC-II are plotted where FCACR is fold change of average cross-correlation and
ACR+CHL, ACR-CHL represent average cross-relation between domains (as shown in S1G and
S1H Table) in presence and absence of cholesterol, respectively.
(TIF)
S1 Table. Cross-correlation of fluctuation for MHC-II domains and peptide in absence
(A-C), presence (D-F) of docked cholesterol and their average (G and H) for three simula-
tion runs. (A-C) Cross-correlation of fluctuation in absence of cholesterol for simulation RUN1,
RUN2 and RUN3, respectively. (D-F) Cross-correlation of fluctuation in presence of cholesterol
for simulation RUN1, RUN2 and RUN3, respectively. (G) Average correlation coefficient values
of fluctuation in absence of cholesterol for simulation RUN1, RUN2 and RUN3. (H) Average
correlation coefficient values of fluctuation in presence of cholesterol for simulation RUN1,
RUN2 and RUN3. PBD_A: Peptide Binding Domain of Chain A; PBD_B: Peptide Binding
Domain of Chain B; MID_A: Middle Domain of Chain A; MID_B: Middle Domain of Chain B;
TM_A: Transmembrane Domain of Chain A; TM_B: Transmembrane Domain of Chain B.
(DOCX)
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